Lupus Nephritis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BIIB | C | Biogen Idec Inc. | -1.84 | |
AUPH | D | Aurinia Pharmaceuticals Inc | 0.74 | |
KYTX | F | Kyverna Therapeutics, Inc. | -4.60 |
Related Industries: Biotechnology Drug Manufacturers - Major
Related Stock Lists:
Lupus
Autoimmune Disease
Biopharmaceutical
Immunosuppressants
Medicine
Multiple Sclerosis
Nephritis
Alzheimer's Disease
Autoimmune Disorders
Autoimmunity
Biotechnology
Cd20
Chronic Lymphocytic Leukemia
Clinical Development
Clinical Trial Product
Clinical Trial Products
Degenerative Disease
Disability
Drugs
Hemophilia
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 6.12 | |
MNTL | B | Tema Neuroscience and Mental Health ETF | 4.68 | |
BBH | B | Market Vectors Biotech ETF | 4.41 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.28 | |
MVAL | D | SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF | 3.88 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Major
Related Stock Lists:
Lupus
Autoimmune Disease
Biopharmaceutical
Immunosuppressants
Medicine
Multiple Sclerosis
Nephritis
Alzheimer's Disease
Autoimmune Disorders
Autoimmunity
Biotechnology
Cd20
Chronic Lymphocytic Leukemia
Clinical Development
Clinical Trial Product
Clinical Trial Products
Degenerative Disease
Disability
Drugs
Hemophilia
- Lupus Nephritis
Lupus nephritis (also known as SLE nephritis) is an inflammation of the kidneys caused by systemic lupus erythematosus (SLE), an autoimmune disease. It is a type of glomerulonephritis in which the glomeruli become inflamed. As the result of SLE, the cause of glomerulonephritis is said to be secondary and has a different pattern and outcome from conditions with a primary cause originating in the kidney.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles